Section: Avian Bacteria

Common Poultry Diseases: A Veterinary Overview of Bacterial and Viral Pathogens

Poultry production faces significant economic losses due to infectious diseases caused by bacterial and viral pathogens. This article provides a detailed veterinary overview of the most common bacterial and viral diseases affecting commercial and backyard poultry flocks. The focus is on pathogenesis, clinical presentation, laboratory diagnostics, and control strategies including vaccination and biosecurity.

Bacterial Pathogens

Salmonellosis

Salmonellosis in poultry is primarily caused by Salmonella enterica subspecies enterica serovars. The two major disease presentations are pullorum disease caused by Salmonella Pullorum and fowl typhoid caused by Salmonella Gallinarum. These host-adapted serovars cause systemic infections in chickens and turkeys.

Pathogenesis. Salmonella Pullorum and Salmonella Gallinarum invade the intestinal epithelium via M cells and enterocytes. The bacteria translocate to the liver, spleen, and bone marrow. In chicks, the organism multiplies in the reticuloendothelial system causing septicemia. Vertical transmission occurs through ovarian infection leading to infected eggs. Horizontal transmission occurs via fecal-oral route and contaminated feed or water.

Clinical Signs. In young chicks, acute mortality with no premonitory signs is common. Surviving chicks show depression, huddling, white pasty diarrhea (pasted vents), and anorexia. In adult birds, fowl typhoid presents with decreased egg production, anorexia, diarrhea, and sudden death. Chronic carriers show no clinical signs but shed bacteria intermittently.

Laboratory Diagnosis. Isolation of Salmonella from liver, spleen, or yolk sac on selective media such as MacConkey agar or xylose lysine deoxycholate (XLD) agar is the gold standard. Biochemical identification and serotyping using O and H antigen agglutination confirm the serovar. Molecular methods include PCR targeting the invA gene. Serological tests include rapid whole blood agglutination and tube agglutination for detecting antibodies in adult flocks.

Control Strategies. Eradication programs based on testing and culling of positive flocks are used in breeding stock. Vaccination with live attenuated or killed bacterins is used in some regions. Biosecurity measures include all-in-all-out management, rodent control, and cleaning and disinfection of facilities.

Colibacillosis

Colibacillosis is caused by avian pathogenic Escherichia coli (APEC). These strains possess specific virulence factors including fimbriae (F1, P, and S fimbriae), toxins (hemolysin, cytotoxic necrotizing factor), and iron acquisition systems (aerobactin). For a detailed discussion, see the article on Avian Pathogenic Escherichia coli (APEC): Virulence Factors, Rapid Diagnostic Assays, and Biosecurity Strategies.

Pathogenesis. APEC colonizes the respiratory tract following inhalation of contaminated dust or feces. The bacteria adhere to respiratory epithelium via fimbriae and evade host defenses. In immunocompromised birds or under stress, APEC translocates to the bloodstream causing septicemia. Fibrinous polyserositis develops in the pericardium, air sacs, and liver capsule.

Clinical Signs. Respiratory signs include rales, coughing, and dyspnea. Septicemic birds show depression, anorexia, and cyanosis. Chronic cases present with pericarditis, perihepatitis, and airsacculitis. In layers, salpingitis and peritonitis cause decreased egg production.

Laboratory Diagnosis. Isolation of E. coli from liver, spleen, or pericardial fluid on MacConkey agar is standard. Hemolytic colonies on blood agar suggest APEC. Serotyping for O antigens (O1, O2, O78) and detection of virulence genes (iss, iroN, ompT, hlyF) by PCR confirm APEC pathotype. Antimicrobial susceptibility testing guides therapy.

Control Strategies. Vaccination with autogenous bacterins or recombinant vaccines targeting virulence factors is used. Antibiotic therapy based on sensitivity testing is employed for treatment. Biosecurity and management practices to reduce ammonia levels and dust are critical.

Mycoplasmosis

Mycoplasmosis in poultry is primarily caused by Mycoplasma gallisepticum and Mycoplasma synoviae. These cell wall deficient bacteria cause chronic respiratory disease and synovitis.

Pathogenesis. M. gallisepticum adheres to respiratory epithelial cells via specialized attachment organelles. The organism causes ciliostasis and loss of ciliary function. It induces a chronic inflammatory response with mononuclear cell infiltration. M. synoviae causes synovitis and tenosynovitis by colonizing the synovial membranes.

Clinical Signs. M. gallisepticum infection presents with rales, coughing, nasal discharge, and conjunctivitis. In layers, egg production drops by 10-20%. M. synoviae causes lameness, swollen joints, and breast blisters. Respiratory signs are less prominent.

Laboratory Diagnosis. Isolation requires specialized media such as Frey's medium or Hayflick's medium. Colonies show typical fried egg appearance. PCR targeting the 16S rRNA gene or species-specific genes (e.g., mgc2 for M. gallisepticum) is highly sensitive. Serological tests include serum plate agglutination (SPA), hemagglutination inhibition (HI), and ELISA.

Control Strategies. Eradication from breeding stock is achieved by testing and culling. Vaccination with live attenuated or inactivated vaccines reduces clinical signs. Antibiotic therapy with tylosin, tiamulin, or enrofloxacin can reduce shedding but does not eliminate infection.

Fowl Cholera

Fowl cholera is caused by Pasteurella multocida serotypes A, D, and F. The disease affects chickens, turkeys, and waterfowl. For a detailed discussion of serotypes and outbreak dynamics, see the article on Avian Cholera in Waterfowl: Pasteurella multocida Serotypes, Outbreak Dynamics, and Vaccination Approaches in Wild and Domestic Birds.

Pathogenesis. P. multocida colonizes the upper respiratory tract and invades the bloodstream. The capsule is a major virulence factor that inhibits phagocytosis. Lipopolysaccharide (LPS) induces endotoxic shock. The bacteria cause fibrinous pneumonia, pericarditis, and septicemia.

Clinical Signs. Peracute cases show sudden death with no clinical signs. Acute cases present with fever, depression, anorexia, mucoid nasal discharge, and diarrhea. Chronic cases show localized infections including wattles edema, arthritis, and conjunctivitis.

Laboratory Diagnosis. Gram staining of blood or tissue smears shows bipolar staining gram-negative coccobacilli. Isolation on blood agar or tryptic soy agar yields characteristic colonies. PCR targeting the KMT1 gene confirms P. multocida. Serotyping by capsular PCR or indirect hemagglutination identifies serogroups.

Control Strategies. Vaccination with killed bacterins or live attenuated vaccines is used in endemic areas. Antibiotic therapy with tetracyclines, sulfonamides, or penicillin is effective. Biosecurity measures include rodent control and preventing contact with wild birds.

Viral Pathogens

Newcastle Disease Virus (NDV)

Newcastle disease is caused by avian paramyxovirus serotype 1 (APMV-1). Strains are classified by pathogenicity as lentogenic (mild), mesogenic (moderate), or velogenic (highly virulent). Velogenic strains cause severe systemic disease.

Pathogenesis. NDV enters via the respiratory or gastrointestinal tract. The virus replicates in epithelial cells and spreads to lymphoid tissues. Velogenic strains cause necrosis of lymphoid organs and hemorrhagic lesions in the gastrointestinal tract. The virus causes fusion of infected cells forming syncytia.

Clinical Signs. Lentogenic strains cause mild respiratory signs and decreased egg production. Mesogenic strains cause respiratory distress, nervous signs (torticollis, tremors), and egg drop. Velogenic strains cause sudden death, severe respiratory distress, greenish diarrhea, and hemorrhagic lesions in the proventriculus and cecal tonsils.

Laboratory Diagnosis. Virus isolation in embryonated chicken eggs via allantoic sac inoculation is the gold standard. Hemagglutination (HA) and hemagglutination inhibition (HI) tests confirm NDV. Real-time RT-PCR targeting the fusion (F) gene detects viral RNA and can differentiate pathotypes based on the F protein cleavage site sequence.

Control Strategies. Vaccination with live lentogenic strains (B1, LaSota) or inactivated vaccines is widely practiced. Biosecurity measures include quarantine of new birds and preventing contact with wild birds. Eradication programs involve stamping out for velogenic strains.

Infectious Bronchitis Virus (IBV)

Infectious bronchitis is caused by a coronavirus (IBV) with multiple serotypes and genotypes. The virus causes respiratory disease, nephritis, and reproductive disorders.

Pathogenesis. IBV enters via the respiratory tract and replicates in ciliated epithelial cells causing ciliostasis and epithelial damage. The virus spreads to the kidneys, oviduct, and gastrointestinal tract. Nephropathogenic strains cause interstitial nephritis. Infection of the oviduct in young pullets leads to permanent damage and false layer syndrome.

Clinical Signs. Respiratory signs include rales, coughing, sneezing, and nasal discharge. In layers, egg production drops by 30-50% with misshapen, soft-shelled, and pale eggs. Nephropathogenic strains cause depression, wet droppings, and increased water consumption.

Laboratory Diagnosis. Virus isolation in embryonated chicken eggs (9-11 days old) via amniotic cavity inoculation causes dwarfing and curling of embryos. RT-PCR targeting the S1 gene followed by sequencing identifies serotypes. Serological tests include HI and ELISA.

Control Strategies. Vaccination with live attenuated vaccines (Massachusetts serotype) and inactivated vaccines is used. Autogenous vaccines are prepared for local serotypes. Biosecurity measures include strict isolation and disinfection.

Infectious Laryngotracheitis (ILT)

Infectious laryngotracheitis is caused by gallid herpesvirus 1 (GaHV-1). The virus causes severe respiratory disease characterized by hemorrhagic tracheitis.

Pathogenesis. ILTV enters via the respiratory tract and replicates in the tracheal epithelium causing necrosis and hemorrhage. The virus establishes latency in the trigeminal ganglion. Reactivation occurs under stress leading to virus shedding.

Clinical Signs. Acute form presents with severe dyspnea, gasping, coughing of bloody mucus, and high mortality (10-50%). Mild form presents with conjunctivitis, sinusitis, and decreased egg production.

Laboratory Diagnosis. Histopathology of trachea shows intranuclear inclusion bodies in epithelial cells. Virus isolation in chicken embryo kidney cells or chicken embryo liver cells shows syncytia formation. PCR targeting the thymidine kinase (TK) gene or glycoprotein genes is highly sensitive.

Control Strategies. Vaccination with live attenuated or recombinant vaccines (fowlpox virus vectored) is used in endemic areas. Biosecurity measures include strict quarantine and disinfection. Eradication involves depopulation of infected flocks.

Marek's Disease Virus (MDV)

Marek's disease is caused by gallid herpesvirus 2 (GaHV-2), an oncogenic alphaherpesvirus. The virus causes T-cell lymphoma and immunosuppression.

Pathogenesis. MDV enters via the respiratory tract and replicates in B lymphocytes. The virus establishes latency in CD4+ T cells. Reactivation leads to transformation of T cells causing lymphoma formation in visceral organs, nerves, and skin. The virus is shed in feather follicle epithelium.

Clinical Signs. Classical form presents with paralysis of legs and wings due to peripheral nerve involvement. Acute form presents with visceral lymphomas causing depression, anorexia, and sudden death. Ocular form causes iris discoloration and blindness. Cutaneous form causes feather follicle tumors.

Laboratory Diagnosis. Gross necropsy shows enlarged nerves (sciatic, brachial) and visceral tumors in liver, spleen, kidney, and ovary. Histopathology shows lymphocytic infiltration and lymphoma. PCR targeting the meq gene or pp38 gene detects MDV DNA. Virus isolation in chicken embryo fibroblast or duck embryo fibroblast cells shows plaque formation.

Control Strategies. Vaccination with live attenuated (CV1988/Rispens) or herpesvirus of turkeys (HVT) vaccines is universally practiced. Vaccination at day of age or in ovo is essential. Biosecurity measures include reducing dust and feather dander.

Differential Diagnosis

The following table summarizes key differentials for common clinical presentations.

Clinical Presentation Bacterial Causes Viral Causes
Respiratory distress M. gallisepticum, P. multocida, E. coli NDV, IBV, ILTV, avian influenza
Diarrhea Salmonella spp., E. coli NDV, IBV (nephropathogenic)
Nervous signs M. gallisepticum (rare) NDV, MDV
Egg production drop M. gallisepticum, E. coli (salpingitis) IBV, NDV, ILTV
Sudden death P. multocida, E. coli (septicemia) Velogenic NDV, highly pathogenic avian influenza
Joint swelling M. synoviae, E. coli None common

Diagnostic Workflow

The following Mermaid diagram illustrates a general diagnostic workflow for poultry disease outbreaks.

flowchart TD
    A[Outbreak Investigation], > B[Clinical Examination and History]
    B, > C[Postmortem Examination]
    C, > D[Sample Collection]
    D, > E{Acute Mortality?}
    E, >|Yes| F[Blood smears, liver, spleen for culture]
    E, >|No| G[Tracheal swabs, fecal samples, serum]
    F, > H[Bacterial Culture and Gram Stain]
    G, > I[Virus Isolation or Molecular Detection]
    H, > J[Biochemical Identification and Serotyping]
    I, > K[RT-PCR or PCR for specific viruses]
    J, > L[Antimicrobial Susceptibility Testing]
    K, > M[Sequencing for pathotyping/genotyping]
    L, > N[Treatment and Control Recommendations]
    M, > N
    N, > O[Biosecurity and Vaccination Review]

Control Strategies Overview

Control of poultry diseases relies on an integrated approach combining vaccination, biosecurity, and management.

Vaccination. Vaccines are available for most major pathogens. Live attenuated vaccines induce strong mucosal and cell-mediated immunity. Inactivated vaccines provide humoral immunity. Recombinant vectored vaccines (e.g., fowlpox virus expressing ILTV glycoproteins) offer safety and efficacy. Vaccination programs must be tailored to local pathogen prevalence and production type.

Biosecurity. Strict biosecurity measures include all-in-all-out management, cleaning and disinfection between flocks, rodent and wild bird control, and quarantine of new birds. Footbaths and dedicated equipment for each house reduce pathogen introduction.

Management. Optimal nutrition, ventilation, and stocking density reduce stress and susceptibility to infection. Ammonia levels below 25 ppm and adequate litter management prevent respiratory disease.

Conclusion

Bacterial and viral pathogens continue to cause significant economic losses in poultry production worldwide. Accurate diagnosis using a combination of clinical examination, postmortem findings, and laboratory testing is essential for effective control. Vaccination and biosecurity remain the cornerstones of disease prevention. Emerging molecular diagnostic tools, including real-time PCR and next-generation sequencing, offer improved sensitivity and the ability to detect mixed infections and emerging variants.

References

  1. Saif YM, Fadly AM, Glisson JR, McDougald LR, Nolan LK, Swayne DE. Diseases of Poultry. 13th ed. Wiley-Blackwell; 2013.
  2. Charlton BR, Bermudez AJ, Boulianne M, et al. Avian Disease Manual. 7th ed. American Association of Avian Pathologists; 2015.
  3. Swayne DE, Glisson JR, Jackwood MW, Pearson JE, Reed WM. A Laboratory Manual for the Isolation and Identification of Avian Pathogens. 5th ed. American Association of Avian Pathologists; 2008.
  4. OIE Terrestrial Manual. Chapter 2.3.14: Newcastle Disease. World Organisation for Animal Health; 2021.
  5. OIE Terrestrial Manual. Chapter 2.3.10: Avian Infectious Bronchitis. World Organisation for Animal Health; 2021.
  6. OIE Terrestrial Manual. Chapter 2.3.9: Infectious Laryngotracheitis. World Organisation for Animal Health; 2021.
  7. OIE Terrestrial Manual. Chapter 2.3.13: Marek's Disease. World Organisation for Animal Health; 2021.
  8. OIE Terrestrial Manual. Chapter 2.9.3: Salmonellosis. World Organisation for Animal Health; 2021.
  9. OIE Terrestrial Manual. Chapter 2.9.7: Avian Mycoplasmosis. World Organisation for Animal Health; 2021.
  10. OIE Terrestrial Manual. Chapter 2.9.11: Fowl Cholera. World Organisation for Animal Health; 2021.